EMAIL THIS PAGE TO A FRIEND

BMC cancer

The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells.


PMID 26345371

Abstract

Recent reports using metabolism regulating drugs showed that nutrient deprivation was an efficient tool to suppress cancer progression. In addition, autophagy control is emerging to prevent cancer cell survival. Autophagy breaks down the unnecessary cytoplasmic components into anabolic units and energy sources, which are the most important sources for making the ATP that maintains homeostasis in cancer cell growth and survival. Therefore, the glucose analog 2-deoxyglucose (2DG) has been used as an anticancer reagent due to its inhibition of glycolysis. Prostate cancer cells (PC3) were treated with 2DG for 6xa0h or 48xa0h to analyze the changing of cell cycle and autophagic flux. Rapamycin and LC3B overexpressing vectors were administered to PC3 cells for autophagy induction and chloroquine and shBeclin1 plasmid were used to inhibit autophagy in PC3 cells to analyze PC3 cells growth and survival. The samples for western blotting were prepared in each culture condition to confirm the expression level of autophagy related and regulating proteins. We demonstrated that 2DG inhibits PC3 cells growth and had discriminating effects on autophagy regulation based on the different time period of 2DG treatment to control cell survival. Short-term treatment of 2DG induced autophagic flux, which increased microtubule associated protein 1 light chain 3B (LC3B) conversion rates and reduced p62 levels. However, 2DG induced autophagic flux is remarkably reduced over an extended time period of 2DG treatment for 48xa0h despite autophagy inducing internal signaling being maintained. The relationship between cell growth and autophagy was proved. Increased autophagic flux by rapamycin or LC3B overexpression powerfully reduced cell growth, while autophagy inhibition with shBeclin1 plasmid or chloroquine had no significant effect on regulating cell growth. Given these results, maintaining increased autophagic flux was more effective at inhibiting cancer cell progression than inhibition of autophagic flux, which is necessary for the survival of PC3 cells. Autophagic flux should be tightly regulated to maintain metabolic homeostasis for cancer cell growth and survival in PC3 cells and is a suitable target for cancer therapy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2100769
Anti-FAM82A (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2100770
Anti-FAM82A (ab2) antibody produced in rabbit, affinity isolated antibody
SAB3500133
Anti-FAM82A1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB2103283
Anti-FAM82B, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB1407628
Anti-FAM82C antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2103199
Anti-FAM82C antibody produced in rabbit, affinity isolated antibody
SAB1305768
ANTI-RMD2 (CENTER) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA026495
Anti-RMDN1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA034706
Anti-RMDN2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA009975
Anti-RMDN3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA022008
Anti-SPAG5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
HPA022479
Anti-SPAG5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
HPA053057
Anti-SYBU antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
WH0010615M1
Monoclonal Anti-SPAG5 antibody produced in mouse, clone 5F9, purified immunoglobulin, buffered aqueous solution
SAB1404850
Monoclonal Anti-SPAG5 antibody produced in mouse, clone 5F9, ascites fluid